Answers are grounded in this paper and cite their sources.
To evaluate real-world utilization of oral corticosteroids (OCS) among patients with generalized myasthenia gravis (gMG) over the first 6 months post-efgartigimod treatment initiation.
No takes yet. Share an insight, caveat, or question.
Goyal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: